Topper David Joseph 4
4 · Arcutis Biotherapeutics, Inc. · Filed Apr 3, 2025
Insider Transaction Report
Form 4
Topper David Joseph
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-04-02$15.80/sh−9,600$151,698→ 182,774 total
Footnotes (2)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs"), granted on April 10, 2024.
- [F2]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $14.61 to $17.26, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.